SAN DIEGO, Sept. 16 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and commercialization of live-cell analysis and manipulation systems, announced today that it has appointed David Burns as the Company's Vice President Sales & Marketing and Chief Operating Officer. David will be responsible for the commercialization of Cyntellect's products and services in the life sciences research market. He joins Cyntellect with an extensive commercial background at leading life sciences companies including GE Healthcare Life Sciences, Amersham and Packard Bioscience.
"David's proven expertise in developing and commercializing system solutions in the life sciences research market, particularly in the cellular bioassay and analysis markets, will accelerate the successful development of Cyntellect's commercial organization and provide us with invaluable strategic leadership as we establish our brand and bring important, high value solutions to life sciences researchers around the world," said Fred Koller, Ph.D., Cyntellect's President and Chief Executive Officer. "We are pleased and proud to have someone of David's caliber, experience, integrity and customer-focused nature join the Cyntellect executive team."
David comes to Cyntellect from GE Healthcare Life Sciences (formerly Amersham Biosciences) where he filled the roles of Head of Strategic Growth, Head of Strategic Business Development and VP Commercial Alliances. Prior to that, he was CEO of Imaging Research Inc. in St. Catharine's, Ontario which was acquired by Amersham in July of 2003. David joined Imaging Research and the Amersham group from a role as Vice-President Business Development and Marketing at Packard-BioSignal Inc., a Packard BioScience subsidiary in Montreal, Quebec. David's prior experience included other executive business development and marketing positions with Packard Bioscience in the USA and Netherlands and in scientific sales with Pharmacia/LKB in the UK. David graduated in Medical Laboratory Sciences from Napier University, Edinburgh.
About Cyntellect
Cyntellect, Inc. is a life sciences company committed to revolutionizing the use of living cells in life science research and cellular therapy. The Company combines expertise in high-speed cell imaging and laser-based manipulation to develop products that enable novel cell imaging, purification, and transfection capabilities to enhance the productivity of laboratory research, recombinant protein production, high-content cellular assays, functional genomics and proteomics, and cell purification, including processing of cells for therapeutic transplantation. For additional information please visit the Company's web site at http://www.cyntellect.com.
CONTACT: Dama L. Linton, Media Relations, +1-858-382-3202,
dama@lintonbiotech.com, for Cyntellect, Inc.
Web site: http://www.cyntellect.com/
